On Thursday, IPOs emerged to be one of the few clear spots in the U. S. market, with new stocks Accretive Health Inc. and ReachLocal Inc. making double-digit percentage increases in their first appearances.

But the rises arrived only after both trimmed down their prices to get their IPOs done, a growingly widespread movement this month among extensive stock instability.

Accretive closed at $13.55 per share on the New York Stock Exchange, was upbeat 12.9% from its initial public offering value of $12.

A whole of 10 million shares, 3.3 million less than initially intended, were retailed at a price less than its anticipated $14 to $16 range.

On the Nasdaq, ReachLocal Inc. closed at $14.98 a share, high 15.2% from its initial public offering price of $13. It vended 4.2 million shares at a price lower than its projected range of $17 to $19.

Chicago-based Accretive Health offers revenue cycle management for hospice and associated physician groups, with 22 clients symbolizing 59 hospitals.

Different from various companies, which offer back-office services to health-care givers, Accretive is not exclusively technology-based. It supplies on-site supplemental workers to help supervise and coach present workers and to manage customers' invoices and groups.